AKT1 and colorectal carcinoma: Similarly, exposure to the SphK1-selective inhibitor-compound 5c attenuated the PI3K/Akt/mTOR cell survival signaling pathway in CRC cells, and enhanced their sensitivity to 5-FU [44].